Psilocybin

10 registered clinical trials studyying Psilocybin — 6 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	The Effects of Psilocybin in Healthy Volunteers: Psychological, Biochemical and Electrophysiological Biomarker NCT07433452	Gabriella Gobbi	Phase 1
Not Yet Recruiting	Psilocybin-Assisted Physical Therapy in Chronic Low Back Pain NCT07306364	Yale University	Phase 2
Not Yet Recruiting	NeuroGuard: Psilocybin Trial for Preventing Chemo-induced Neuropathy NCT07227909	M.D. Anderson Cancer Center	Phase 2
Enrolling By Invitation	PRoMiSS: Psilocybin and the Role of Music in Set and Setting NCT07180108	Johns Hopkins University	Phase 1
Recruiting	The RECAP2 Study: Midazolam and Psilocybin NCT06692192	University of Wisconsin, Madison	Phase 1
Recruiting	Psychedelic-assisted Group Program for First Responders NCT06471959	Empower Research Inc	Phase 1 / Phase 2
Completed	Evaluation of the Effect of a Single Dose of Psilocybin on Neural Correlates of Cognitive Control in Patients NCT06647056	Centre Hospitalier Universitaire de Nīmes	N/A
Completed	Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care NCT04950608	Yvan Beaussant, MD, MSci	Phase 2
Completed	Precision Functional Brain Mapping in Psilocybin NCT04501653	Washington University School of Medicine	EARLY_Phase 1
Completed	Pilot Study: Effects of Psilocybin on Behavior, Psychology and Brain Function in Long-term Meditators NCT01988311	Johns Hopkins University	Phase 1